Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$12.97
-3.67%
Mkt Cap $1.10B
Analyst Ratings
Buy
6
Hold
7
Sell
2
Price Target (18 analysts)
$14.00
Range $12.00 – $16.00
Implied Upside
+7.9%
Consensus $14.00 vs current $12.97
NASDAQ·Healthcare·Biotechnology
$12.97
-3.67%
Mkt Cap $1.10B
Buy
6
Hold
7
Sell
2
Price Target (18 analysts)
$14.00
Range $12.00 – $16.00
+7.9%
Consensus $14.00 vs current $12.97